Fresenius Kabi

Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for critically and chronically ill patients. Its core business focuses on four key expertise fields: biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs. The company operates a sophisticated international infrastructure, including approximately 60 production sites and compounding centers worldwide, which allows it to supply a comprehensive range of infusion, transfusion, and parenteral nutrition products. By integrating manufacturing, supply chain logistics, and research, Fresenius Kabi develops and delivers system-critical solutions that support healthcare professionals in daily medical procedures and improve patient outcomes.

The company's mission, centered on the commitment to life, serves the critical needs of hospitals and patients globally. By providing accessible, high-quality, and cost-effective pharmaceutical products, devices, and therapies, Fresenius Kabi helps ease clinical workflows and enhance the quality of care for caregivers and patients alike. With more than 41,000 employees and a presence in over 100 countries, the organization plays a vital role in the global healthcare landscape. Through its diverse portfolio and focus on innovation, the company addresses shifting demographic demands and changing technological needs, ensuring reliable and essential support for patients facing challenging medical situations.